Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 5, 1999
T cells mediate treatment of six-day-old cytokine-gene-transfected mouse mammary tumor
Y L Matory, D M Dorfman, M Chen, et al.
Journal of Biological Response Modifiers
|
August 1, 1985
Toxicity of recombinant human interleukin-2 in rats following intravenous infusion
Y L Matory, A E Chang, E H Lipford, et al.
Cancer
|
December 15, 1986
Clinical effects and toxicity of interleukin-2 in patients with cancer
M T Lotze, Y L Matory, A A Rayner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1985
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2
M T Lotze, Y L Matory, S E Ettinghausen, et al.
The New England Journal of Medicine
|
December 5, 1985
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
S A Rosenberg, M T Lotze, L M Muul, et al.
Annals of Surgery
|
April 1, 1987
Magnetic resonance imaging versus computed tomography in the evaluation of soft tissue tumors of the extremities
A E Chang, Y L Matory, A J Dwyer, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 5, 1999
T cells mediate treatment of six-day-old cytokine-gene-transfected mouse mammary tumor
Y L Matory, D M Dorfman, M Chen, et al.
Journal of Biological Response Modifiers
|
August 1, 1985
Toxicity of recombinant human interleukin-2 in rats following intravenous infusion
Y L Matory, A E Chang, E H Lipford, et al.
Cancer
|
December 15, 1986
Clinical effects and toxicity of interleukin-2 in patients with cancer
M T Lotze, Y L Matory, A A Rayner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1985
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2
M T Lotze, Y L Matory, S E Ettinghausen, et al.
The New England Journal of Medicine
|
December 5, 1985
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
S A Rosenberg, M T Lotze, L M Muul, et al.
Annals of Surgery
|
April 1, 1987
Magnetic resonance imaging versus computed tomography in the evaluation of soft tissue tumors of the extremities
A E Chang, Y L Matory, A J Dwyer, et al.
Page
of 2